JP2019511496A5 - - Google Patents

Download PDF

Info

Publication number
JP2019511496A5
JP2019511496A5 JP2018548363A JP2018548363A JP2019511496A5 JP 2019511496 A5 JP2019511496 A5 JP 2019511496A5 JP 2018548363 A JP2018548363 A JP 2018548363A JP 2018548363 A JP2018548363 A JP 2018548363A JP 2019511496 A5 JP2019511496 A5 JP 2019511496A5
Authority
JP
Japan
Prior art keywords
dose
salt
administered
day
administering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018548363A
Other languages
English (en)
Japanese (ja)
Other versions
JP7224916B2 (ja
JP2019511496A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/022551 external-priority patent/WO2017161016A1/en
Publication of JP2019511496A publication Critical patent/JP2019511496A/ja
Publication of JP2019511496A5 publication Critical patent/JP2019511496A5/ja
Priority to JP2022125186A priority Critical patent/JP7322259B2/ja
Application granted granted Critical
Publication of JP7224916B2 publication Critical patent/JP7224916B2/ja
Priority to JP2023121182A priority patent/JP2023139211A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018548363A 2016-03-16 2017-03-15 真菌感染の処置のための投薬レジメン Active JP7224916B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2022125186A JP7322259B2 (ja) 2016-03-16 2022-08-05 真菌感染の処置のための投薬レジメン
JP2023121182A JP2023139211A (ja) 2016-03-16 2023-07-26 真菌感染の処置のための投薬レジメン

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US201662309211P 2016-03-16 2016-03-16
US62/309,211 2016-03-16
US201662350591P 2016-06-15 2016-06-15
US62/350,591 2016-06-15
US201662415928P 2016-11-01 2016-11-01
US62/415,928 2016-11-01
US201662418727P 2016-11-07 2016-11-07
US62/418,727 2016-11-07
US201662419076P 2016-11-08 2016-11-08
US62/419,076 2016-11-08
US201662436716P 2016-12-20 2016-12-20
US62/436,716 2016-12-20
PCT/US2017/022551 WO2017161016A1 (en) 2016-03-16 2017-03-15 Dosing regimens for treatment of fungal infections

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022125186A Division JP7322259B2 (ja) 2016-03-16 2022-08-05 真菌感染の処置のための投薬レジメン

Publications (3)

Publication Number Publication Date
JP2019511496A JP2019511496A (ja) 2019-04-25
JP2019511496A5 true JP2019511496A5 (https=) 2020-05-07
JP7224916B2 JP7224916B2 (ja) 2023-02-20

Family

ID=59850952

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018548363A Active JP7224916B2 (ja) 2016-03-16 2017-03-15 真菌感染の処置のための投薬レジメン
JP2022125186A Active JP7322259B2 (ja) 2016-03-16 2022-08-05 真菌感染の処置のための投薬レジメン
JP2023121182A Pending JP2023139211A (ja) 2016-03-16 2023-07-26 真菌感染の処置のための投薬レジメン

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022125186A Active JP7322259B2 (ja) 2016-03-16 2022-08-05 真菌感染の処置のための投薬レジメン
JP2023121182A Pending JP2023139211A (ja) 2016-03-16 2023-07-26 真菌感染の処置のための投薬レジメン

Country Status (8)

Country Link
US (2) US11712459B2 (https=)
EP (2) EP4268896A3 (https=)
JP (3) JP7224916B2 (https=)
CN (1) CN109154603A (https=)
CA (1) CA3017485A1 (https=)
ES (1) ES2955711T3 (https=)
MA (1) MA43825A (https=)
WO (1) WO2017161016A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012119065A2 (en) 2011-03-03 2012-09-07 Seachaid Pharmaceuticals, Inc. Antifungal agents and uses thereof
SI3677252T1 (sl) 2012-03-19 2024-02-29 Cidara Therapeutics, Inc. Sheme odmerjanja za spojine iz razreda ehinokandinov
CN108883152A (zh) 2016-01-08 2018-11-23 奇达拉治疗公司 防止和治疗肺孢子虫感染的方法
MA43825A (fr) 2016-03-16 2021-04-07 Cidara Therapeutics Inc Schémas posologiques pour le traitement d'infections fongiques
JP7779651B2 (ja) 2017-07-12 2025-12-03 ナップ ファーマシューティカル グループ リミテッド 真菌感染症の処置のための組成物及び方法
EP3806882A4 (en) 2018-06-15 2022-03-23 Cidara Therapeutics, Inc. SYNTHESIS OF AN ANTIFUNGAL WITH ECHINOCANDIN
WO2020086931A1 (en) 2018-10-25 2020-04-30 Cidara Therapeutics, Inc. Polymorph of echinocandin antifungal agent
AU2020276595B2 (en) * 2019-05-16 2025-12-04 Scynexis, Inc. Antifungal Agents for Candida Auris Decolonization

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4427660A (en) 1982-03-03 1984-01-24 Research Corporation Formyl-methionyl chemotatic peptide antibiotic conjugates useful in treating infections
US5166135A (en) 1988-09-12 1992-11-24 Merck & Company, Inc. Method for the control of pneumocystis carinii
US6030944A (en) 1991-10-01 2000-02-29 Merck & Co., Inc. Cyclohexapeptidyl bisamine compounds
US5399552A (en) 1991-10-17 1995-03-21 Merck & Co, Inc Antibiotic peptides bearing aminoalkylthioether moieties
US5378804A (en) 1993-03-16 1995-01-03 Merck & Co., Inc. Aza cyclohexapeptide compounds
US6268338B1 (en) 1993-04-30 2001-07-31 Merck & Co., Inc. Cyclohexapeptidyl amine compounds
US5948753A (en) 1993-05-04 1999-09-07 Merck & Co., Inc. Cyclohexapeptidyl propanolamine compounds
JPH09500103A (ja) 1993-05-04 1997-01-07 メルク エンド カンパニー インコーポレーテッド シクロヘキサペプチジルアミノアルキルエーテル
US5541160A (en) 1994-04-04 1996-07-30 Merck & Co., Inc. Antifungal and anti-pneumocystis compounds, compositions containing such compounds, and methods of use
US5514651A (en) 1994-09-16 1996-05-07 Merck & Co., Inc. Aza cyclohexapeptide compounds
US5516756A (en) 1994-10-31 1996-05-14 Merck & Co., Inc. Aza cyclohexapeptide compounds
WO1996022784A1 (en) 1995-01-26 1996-08-01 Merck & Co., Inc. Novel antifungal cyclohexapeptides
US5652213A (en) 1995-05-26 1997-07-29 Eli Lilly And Company Cyclic peptide antifungal agents
PE63998A1 (es) 1996-04-19 1998-10-30 Merck & Co Inc Composiciones anti-fungosas
US6069126A (en) 1996-09-12 2000-05-30 Merck & Co., Inc. Antifungal combination therapy
DK1137663T3 (da) 1998-12-09 2007-01-08 Lilly Co Eli Oprensning af Echinocandin-cyclopeptidforbindelser
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
HK1040062A1 (zh) 1999-03-03 2002-05-24 Eli Lilly And Company 含有成胶束表面活性剂的棘白菌素药物配方
HK1040369A1 (zh) 1999-03-03 2002-06-07 Eli Lilly And Company 制备药物口服ecb配方和组合物的方法
US6309622B1 (en) * 1999-03-26 2001-10-30 Protech Professional Products, Inc. Antimicrobial denture cleansing compositions
CN1355699A (zh) * 1999-04-16 2002-06-26 藤泽药品工业株式会社 抗真菌组合物
HU0104790D0 (en) 2001-11-08 2002-01-28 Human Rt Pharmaceutical combinations for topical application
US6991800B2 (en) 2002-06-13 2006-01-31 Vicuron Pharmaceuticals Inc. Antifungal parenteral products
US20060276339A1 (en) 2002-10-16 2006-12-07 Windsor J B Methods and compositions for increasing the efficacy of biologically-active ingredients
US6913759B2 (en) 2003-03-11 2005-07-05 Curatek Pharmaceuticals Holding, Inc. Gel composition and method for treatment of vaginal infections
ATE381957T1 (de) 2003-07-22 2008-01-15 Theravance Inc Verwendung eines antimykotischen echinocandin- mittels in kombination mit einem antibakteriellen glycopeptid-mittel
US20060140990A1 (en) * 2003-09-19 2006-06-29 Drugtech Corporation Composition for topical treatment of mixed vaginal infections
US8753819B2 (en) 2005-07-26 2014-06-17 Rutgers, The State University Of New Jersey Assays for resistance to echinocandin-class drugs
WO2007113386A1 (en) 2006-03-31 2007-10-11 Karyon-Ctt Ltd Peptide conjugates
GB0702020D0 (en) 2007-02-02 2007-03-14 Novabiotics Ltd Peptides and their use
US20090238867A1 (en) 2007-12-13 2009-09-24 Scott Jenkins Nanoparticulate Anidulafungin Compositions and Methods for Making the Same
US20100009009A1 (en) 2008-07-10 2010-01-14 Micropure, Inc. Method and composition for prevention and treatment of oral fungal infections
GB0817121D0 (en) 2008-09-18 2008-10-29 Univ St Andrews Anti-fungal therapy
CN102438590B (zh) 2009-02-25 2013-07-10 施泰福研究澳大利亚有限公司 局部泡沫组合物
WO2010128096A1 (en) 2009-05-07 2010-11-11 Dsm Ip Assets B.V. Method for the preparation of cyclopeptides
DK2470168T3 (en) 2009-08-26 2018-05-07 Bioelectron Tech Corp PROCEDURES FOR PREVENTION AND TREATMENT OF CEREBRAL ISCAM
EP2470190A4 (en) 2009-08-27 2013-07-17 Seachaid Pharmaceuticals Inc ECHINOCANDINDERIVATE
WO2011089214A1 (en) 2010-01-22 2011-07-28 Ascendis Pharma As Carrier-linked carbamate prodrug linkers
WO2012119065A2 (en) 2011-03-03 2012-09-07 Seachaid Pharmaceuticals, Inc. Antifungal agents and uses thereof
EP2739652B1 (en) 2011-08-04 2017-04-05 Medizinische Universität Innsbruck Cahgt1p inhibitors for use in the treatment of candidiasis
US8829053B2 (en) 2011-12-07 2014-09-09 Rochal Industries Llp Biocidal compositions and methods of using the same
SI3677252T1 (sl) * 2012-03-19 2024-02-29 Cidara Therapeutics, Inc. Sheme odmerjanja za spojine iz razreda ehinokandinov
CN102766198A (zh) 2012-05-04 2012-11-07 中国人民解放军第二军医大学 一种糖肽类抗真菌化合物及其制备方法与应用
WO2014113693A1 (en) 2013-01-18 2014-07-24 University Of Utah Research Foundation Modified release osmotic pump for ph-responsive intravaginal drug delivery
WO2014124504A1 (en) 2013-02-13 2014-08-21 Katholieke Universiteit Leuven Ku Leuven Research & Development Compositions and methods for treating biofilms
WO2014145109A1 (en) 2013-03-15 2014-09-18 Arizona Board Of Regents, For And On Behalf Of, Arizona State University Sugar-linker-drug conjugates
AU2014262127B2 (en) 2013-05-01 2019-05-02 Neoculi Pty Ltd Methods for treating bacterial infections
WO2015035102A2 (en) * 2013-09-04 2015-03-12 Cidara Therapeutics, Inc. Compositions and methods for the treatment of fungal infections
WO2017049102A1 (en) 2015-09-16 2017-03-23 Cidara Therapeutics, Inc. Methods for treating fungal infections
WO2017049105A1 (en) 2015-09-16 2017-03-23 Cidara Therapeutics, Inc. Formulations for treating fungal infections
CN108883152A (zh) 2016-01-08 2018-11-23 奇达拉治疗公司 防止和治疗肺孢子虫感染的方法
MA43825A (fr) 2016-03-16 2021-04-07 Cidara Therapeutics Inc Schémas posologiques pour le traitement d'infections fongiques
CN110290797A (zh) 2016-11-01 2019-09-27 奇达拉治疗公司 用于预防和治疗真菌感染的单剂量方法
WO2018102407A1 (en) 2016-11-29 2018-06-07 Cidara Therapeutics, Inc Methods for preventing fungal infections
EP3577129A1 (en) 2017-01-31 2019-12-11 Cidara Therapeutics, Inc. Methods for treating fungal infections
WO2018187574A1 (en) 2017-04-05 2018-10-11 Cidara Therapeutics, Inc. Compositions and methods for the treatment of fungal infections
WO2018191692A1 (en) 2017-04-14 2018-10-18 Cidara Therapeutics, Inc. Methods for treating fungal infections
JP7779651B2 (ja) 2017-07-12 2025-12-03 ナップ ファーマシューティカル グループ リミテッド 真菌感染症の処置のための組成物及び方法
KR20200047550A (ko) 2017-08-03 2020-05-07 시다라 세라퓨틱스, 인코포레이티드 복강내 칸디다증의 예방 방법 및 치료 방법
EP3806882A4 (en) 2018-06-15 2022-03-23 Cidara Therapeutics, Inc. SYNTHESIS OF AN ANTIFUNGAL WITH ECHINOCANDIN

Similar Documents

Publication Publication Date Title
JP2019511496A5 (https=)
JP2012131811A5 (https=)
JP2017503820A5 (https=)
JP6923206B2 (ja) マイコバクテリア感染症及び肺疾患を治療するための組成物及び方法
IL314873A (en) Compositions and methods for treating disorders ameliorated by muscarnic receptor activation
JP2012522037A5 (https=)
JP2016034978A5 (https=)
CA3019769C (en) Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa
JP2015523355A5 (https=)
JP2006504795A5 (https=)
JP2012530723A5 (https=)
JP2013500977A5 (https=)
JP2012502047A5 (https=)
JP2013541583A5 (https=)
JP2018509388A5 (https=)
JP2012525391A5 (https=)
JP2017519762A5 (https=)
JP2013540734A5 (https=)
JP2015514093A5 (https=)
CN103735570A (zh) 一种预防口腔真菌感染的口腔护理液
Bamba et al. A case of vocal cord cyst with cryptococcal infection
CN107920994A (zh) 用于治疗目的的板层小体的组合物和方法
Rodrigues et al. Disinfectants to fight oral candida biofilms
D'Urzo et al. Long-term extension study of ACCORD COPD I: effects of two doses of twice-daily aclidinium bromide in COPD patients
JP2021102605A5 (https=)